Hejian Zou

4.2k total citations · 1 hit paper
126 papers, 2.7k citations indexed

About

Hejian Zou is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Hejian Zou has authored 126 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pathology and Forensic Medicine, 40 papers in Molecular Biology and 35 papers in Immunology. Recurrent topics in Hejian Zou's work include Gout, Hyperuricemia, Uric Acid (33 papers), Systemic Sclerosis and Related Diseases (29 papers) and Spondyloarthritis Studies and Treatments (12 papers). Hejian Zou is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (33 papers), Systemic Sclerosis and Related Diseases (29 papers) and Spondyloarthritis Studies and Treatments (12 papers). Hejian Zou collaborates with scholars based in China, United States and Hong Kong. Hejian Zou's co-authors include Xiaoxia Zhu, Minrui Liang, Yu Xue, Jiucun Wang, Xue Yang, Weiguo Wan, Jianhua Qiu, Yiyun Yu, Jin Li and Xiaodong Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Hejian Zou

121 papers receiving 2.7k citations

Hit Papers

Prevalence of Hyperuricemia Among Chinese Adults: Finding... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hejian Zou China 31 869 709 649 627 520 126 2.7k
Yan Liang China 28 732 0.8× 704 1.0× 348 0.5× 203 0.3× 797 1.5× 123 3.2k
Norihiko Sakai Japan 34 1.0k 1.2× 805 1.1× 316 0.5× 1.2k 1.9× 407 0.8× 110 3.7k
Beom Jin Lim South Korea 29 582 0.7× 470 0.7× 434 0.7× 970 1.5× 249 0.5× 163 2.8k
Kazuhiro Dohi Japan 31 1.1k 1.2× 866 1.2× 357 0.6× 918 1.5× 640 1.2× 153 3.8k
Jong Dae Ji South Korea 36 1.1k 1.3× 1.7k 2.4× 574 0.9× 248 0.4× 1.9k 3.6× 160 4.6k
Suxia Wang China 32 978 1.1× 813 1.1× 481 0.7× 1.9k 3.1× 703 1.4× 234 3.7k
Bin Yoo South Korea 33 666 0.8× 674 1.0× 499 0.8× 374 0.6× 1.7k 3.2× 213 3.9k
Shun‐le Chen China 26 910 1.0× 1.4k 1.9× 878 1.4× 175 0.3× 1.5k 2.9× 61 3.7k
Joseph C.K. Leung Hong Kong 34 819 0.9× 750 1.1× 386 0.6× 1.5k 2.4× 242 0.5× 76 3.1k
George Vaiopoulos Greece 30 631 0.7× 435 0.6× 417 0.6× 103 0.2× 651 1.3× 161 3.1k

Countries citing papers authored by Hejian Zou

Since Specialization
Citations

This map shows the geographic impact of Hejian Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hejian Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hejian Zou more than expected).

Fields of papers citing papers by Hejian Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hejian Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hejian Zou. The network helps show where Hejian Zou may publish in the future.

Co-authorship network of co-authors of Hejian Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Hejian Zou. A scholar is included among the top collaborators of Hejian Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hejian Zou. Hejian Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Yu, et al.. (2025). Exosomes carrying adipose mesenchymal stem cells function alleviate scleroderma skin fibrosis by inhibiting the TGF-β1/Smad3 axis. Scientific Reports. 15(1). 7162–7162. 4 indexed citations
2.
Li, Zhijian, Wenjie Xie, Wenjing Ye, et al.. (2025). Spatial multiomics decipher fibroblast–macrophage dynamics in systemic sclerosis. Annals of the Rheumatic Diseases. 84(7). 1231–1245. 3 indexed citations
3.
Zhang, Xiaoyun, et al.. (2025). Mitochondrial dysfunction in fibrotic diseases: Research progress and MSC-exos therapy. Experimental and Molecular Pathology. 143. 104983–104983.
5.
Zhang, Fa‐Li, Yu Xiao, Yingyu Wang, et al.. (2024). Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts. Free Radical Biology and Medicine. 221. 23–30. 10 indexed citations
6.
Liang, Minrui, Andrea‐Hermina Györfi, Yinan Li, et al.. (2024). Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis. Science Translational Medicine. 16(740). eadd6570–eadd6570. 16 indexed citations
7.
Jiang, Shuai, Qing Zhang, Lu Bai, et al.. (2024). Iron metabolism and arthritis: Exploring connections and therapeutic avenues. Chinese Medical Journal. 137(14). 1651–1662. 6 indexed citations
8.
Xue, Ying, Jian Hu, Huaxiang Wu, et al.. (2023). AB0968 RAPID ONSET OF EFFICACY IN CHINESE PATIENTS WITH ACTIVE RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS TREATED WITH IXEKIZUMAB: A PHASE 3 STUDY. Annals of the Rheumatic Diseases. 82. 1703–1703. 1 indexed citations
10.
Wei, Yanxia, Na Peng, Chong Deng, et al.. (2022). Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sjogren’s syndrome. Cellular and Molecular Immunology. 19(12). 1361–1372. 22 indexed citations
11.
Xiao, Fan, Ke Rui, Xiaofei Shi, et al.. (2022). Epigenetic regulation of B cells and its role in autoimmune pathogenesis. Cellular and Molecular Immunology. 19(11). 1215–1234. 43 indexed citations
12.
Pu, Weilin, Rui Zhang, Yanyun Ma, et al.. (2021). Genetic Associations of Non–Major Histocompatibility Complex Susceptibility Loci with Systemic Sclerosis in a Han Chinese Population. Journal of Investigative Dermatology. 142(7). 2039–2042.e7. 1 indexed citations
13.
Xiao, Fan, Wenhan Du, Xiaoxia Zhu, et al.. (2021). IL‐17 drives salivary gland dysfunction via inhibiting TRPC1‐mediated calcium movement in Sjögren’s syndrome. Clinical & Translational Immunology. 10(4). e1277–e1277. 20 indexed citations
14.
Yu, Yiyun, Jie Yang, Yu Xue, et al.. (2019). Leptin Promotes Monosodium Urate Crystal–Induced Inflammation in Human and Murine Models of Gout. The Journal of Immunology. 202(9). 2728–2736. 26 indexed citations
15.
16.
Liang, Minrui, et al.. (2017). Polyneuropathy as Novel Initial Manifestation in a Case of “Nonsecretory” POEMS Syndrome with Sjögren’s Syndrome. Case Reports in Medicine. 2017. 1–6. 3 indexed citations
17.
Niu, Zhenmin, Jiucun Wang, Hejian Zou, et al.. (2015). Common MIR146A Polymorphisms in Chinese Ankylosing Spondylitis Subjects and Controls. PLoS ONE. 10(9). e0137770–e0137770. 24 indexed citations
18.
Zhou, Xiaodong, Michael H. Weisman, Michael M. Ward, et al.. (2014). Shared HLA Class I and II Alleles in Susceptibility to Ankylosing Spondylitis Among Three Ethnic Groups.. Queensland's institutional digital repository (The University of Queensland). 66. 1 indexed citations
19.
Wu, Ting, Haiyan Chu, Wenzhen Tu, et al.. (2014). Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis. BMC Complementary and Alternative Medicine. 14(1). 224–224. 25 indexed citations
20.
Yu, Bo, Ming Guan, Yinghui Peng, et al.. (2011). Copy number variations of interleukin‐17F, interleukin‐21, and interleukin‐22 are associated with systemic lupus erythematosus. Arthritis & Rheumatism. 63(11). 3487–3492. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026